Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients (Q24244555)

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Fluconazole improves survival in septic shock: a randomized double-blind prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Ketoconazole to prevent acute respiratory distress syndrome in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Ketoconazole and pulmonary failure after esophagectomy: a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Confidence intervals for the number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Reliability of clinical research on invasive fungal infections: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Effects of nosocomial candidemia on outcomes of critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Antifungal prophylaxis for intensive care unit patients: let's fine tune it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Temporal assessment of Candida risk factors in the surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

New approaches to the risk of Candida in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Candida colonization and subsequent infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Prophylactic antifungal therapy in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

Candida infections in critically ill trauma patients: a retrospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Ketoconazole prevents Candida sepsis in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Antifungal agents for preventing fungal infections in non-neutropenic critically-ill patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Systemic candidiasis in intensive care units: A multicenter, matched-cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Invasive candidiasis: turning risk into a practical prevention policy?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Ketoconazole for prophylaxis of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Ketoconazole prevents acute respiratory failure in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Bioavailability of fluconazole in surgical intensive care unit patients: a study comparing routes of administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Fluconazole increases bactericidal activity of neutrophils

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004920.PUB2

7 January 2021

10.1002/14651858.CD004920.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2063486

2063486

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference